These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1972321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J.
    BMJ; 1991 Jan 12; 302(6768):73-8. PubMed ID: 1671651
    [Abstract] [Full Text] [Related]

  • 5. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB, Chmiel JS, Poggensee L, Wu S, Phair JP.
    Am J Med; 1990 Dec 12; 89(6):706-12. PubMed ID: 1979205
    [Abstract] [Full Text] [Related]

  • 6. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
    Mulder JW, Krijnen P, Coutinho RA, Bakker M, Goudsmit J, Lange JM.
    Genitourin Med; 1991 Jun 12; 67(3):188-93. PubMed ID: 1906425
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
    Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM.
    AIDS; 1994 Mar 12; 8(3):313-21. PubMed ID: 7913326
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR, Weinstein RA, Whaling SM, Ou CY, Connolly PJ, Moore JL, Bitran JD.
    J Infect Dis; 1992 May 12; 165(5):793-8. PubMed ID: 1349031
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE.
    AIDS; 1992 Aug 12; 6(8):821-5. PubMed ID: 1418778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HIV antigen variability in ARC/AIDS.
    Hendrix CW, Volberding PA, Chaisson RE.
    J Acquir Immune Defic Syndr (1988); 1991 Aug 12; 4(9):847-50. PubMed ID: 1910082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.